{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:35:42Z","timestamp":1792758942511,"version":"4.5.0"},"reference-count":139,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jaip.2025.05.002","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T17:36:16Z","timestamp":1746725776000},"page":"1542-1552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Treatable Traits as a Pathway to Remission in Asthma"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-8547","authenticated-orcid":false,"given":"In\u00eas","family":"Farinha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter G.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa M.","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam G.","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.05.002_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5414\/ALX02445E","article-title":"Asthma therapy concepts through the ages","volume":"8","author":"Lommatzsch","year":"2024","journal-title":"Allergol Select"},{"key":"10.1016\/j.jaip.2025.05.002_bib3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.chest.2019.10.053","article-title":"Characterization of severe asthma Worldwide: Data From the International Severe Asthma Registry","volume":"157","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib4","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/09031936.00120714","article-title":"From the authors: International European Respiratory Society\/American Thoracic Society guidelines on severe asthma","volume":"44","author":"Chung","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib5","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fmed.2020.00191","article-title":"Airway remodeling in asthma","volume":"7","author":"Hough","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2025.05.002_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jaip.2014.05.005","article-title":"The prevalence of severe asthma and low asthma control among Danish adults","volume":"2","author":"von Bulow","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02583-2021","article-title":"Asthma remission: what is it and how can it be achieved?","volume":"60","author":"Thomas","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib8","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(22)00331-2","article-title":"Disease-modifying anti-asthmatic drugs","volume":"399","author":"Lommatzsch","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaip.2020.10.035","article-title":"The relationship of asthma biologics to remission for asthma","volume":"9","author":"Menzies-Gow","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pharmthera.2011.01.002","article-title":"Remission of asthma: the next therapeutic frontier?","volume":"130","author":"Upham","year":"2011","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaip.2025.05.002_bib11","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jaci.2019.12.006","article-title":"An expert consensus framework for asthma remission as a treatment goal","volume":"145","author":"Menzies-Gow","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib12","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12325-022-02098-1","article-title":"Clinical remission in severe asthma: a pooled post hoc analysis of the patient journey with benralizumab","volume":"39","author":"Menzies-Gow","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.05.002_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1136\/oem.2010.055129","article-title":"Medical surveillance programme for diisocyanate exposure","volume":"68","author":"Labrecque","year":"2011","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1136\/ard.2010.133850","article-title":"Definition of remission and relapse in polymyalgia rheumatica: data from a literature search compared with a Delphi-based expert consensus","volume":"70","author":"Dejaco","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.05.002_bib15","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1136\/ard.54.12.944","article-title":"Early rheumatoid arthritis: time to aim for remission?","volume":"54","author":"Emery","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.05.002_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13555-020-00475-8","article-title":"Treat-to-target approach for the management of patients with moderate-to-severe plaque psoriasis: consensus recommendations","volume":"11","author":"Gisondi","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaip.2025.05.002_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nrrheum.2009.253","article-title":"Rheumatoid arthritis: can we achieve true drug-free remission in patients with RA?","volume":"6","author":"Goekoop-Ruiterman","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jaip.2025.05.002_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","article-title":"Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force","volume":"75","author":"Smolen","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.05.002_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/acr.20021","article-title":"Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review","volume":"62","author":"van Tuyl","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jaip.2025.05.002_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/apt.13948","article-title":"Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus","volume":"45","author":"Vuitton","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaip.2025.05.002_bib21","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1136\/bmj.280.6229.1397","article-title":"The natural history of childhood asthma to adult life","volume":"280","author":"Martin","year":"1980","journal-title":"BMJ"},{"key":"10.1016\/j.jaip.2025.05.002_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1067\/mai.2002.120951","article-title":"The Melbourne Asthma Study: 1964-1999","volume":"109","author":"Phelan","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib23","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1016\/j.jaip.2021.06.041","article-title":"Defining a severe asthma super-responder: findings from a Delphi process","volume":"9","author":"Upham","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0140-6736(10)61087-2","article-title":"Asthma in older adults","volume":"376","author":"Gibson","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ageing\/afq134","article-title":"Multidimensional assessment of older people with asthma and COPD: clinical management and health status","volume":"40","author":"McDonald","year":"2011","journal-title":"Age Ageing"},{"key":"10.1016\/j.jaip.2025.05.002_bib26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1136\/thoraxjnl-2012-202646","article-title":"Multidimensional assessment and tailored interventions for COPD: respiratory utopia or common sense?","volume":"68","author":"McDonald","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.05.002_bib27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1183\/13993003.01359-2015","article-title":"Treatable traits: toward precision medicine of chronic airway diseases","volume":"47","author":"Agusti","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib28","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01655-2017","article-title":"Precision medicine in airway diseases: moving to clinical practice","volume":"50","author":"Agusti","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02058-2018","article-title":"Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report","volume":"53","author":"McDonald","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2169\/internalmedicine.3353-23","article-title":"Clinical benefits of targeting treatable traits in asthma and chronic obstructive pulmonary disease","volume":"64","author":"Morishima","year":"2025","journal-title":"Intern Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/resp.13389","article-title":"Treatable traits can be identified in a severe asthma registry and predict future exacerbations","volume":"24","author":"McDonald","year":"2019","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2025.05.002_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/resp.14644","article-title":"Treatable traits models of care","volume":"29","author":"McDonald","year":"2024","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2025.05.002_bib33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-2600(23)00461-7","article-title":"GOLD COPD report: 2024 update","volume":"12","author":"Venkatesan","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib34","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0143-2023","article-title":"From treatable traits to GETomics in airway disease: moving towards clinical practice","volume":"33","author":"Papi","year":"2024","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jaip.2025.05.002_bib35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: a network-based approach to human disease","volume":"12","author":"Barabasi","year":"2011","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.jaip.2025.05.002_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2021.106572","article-title":"Moving towards a treatable traits model of care for the management of obstructive airways diseases","volume":"187","author":"Agusti","year":"2021","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5694\/mja2.51464","article-title":"Treatable traits in asthma: moving beyond diagnostic labels","volume":"216","author":"McDonald","year":"2022","journal-title":"Med J Aust"},{"key":"10.1016\/j.jaip.2025.05.002_bib38","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaip.2023.01.011","article-title":"Treatable traits in airway disease: from theory to practice","volume":"11","author":"Agusti","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib39","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01509-2019","article-title":"Targeting treatable traits in severe asthma: a randomised controlled trial","volume":"55","author":"McDonald","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib40","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.jaip.2022.05.012","article-title":"Effectiveness of interventions targeting treatable traits for the management of obstructive airway diseases: a systematic review and meta-analysis","volume":"10","author":"Sarwar","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib41","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/resp.13134","article-title":"Multidimensional assessment of severe asthma: a systematic review and meta-analysis","volume":"22","author":"Clark","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2025.05.002_bib42","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.jaip.2019.12.037","article-title":"Systematic assessment for difficult and severe asthma improves outcomes and halves oral corticosteroid burden independent of monoclonal biologic use","volume":"8","author":"Denton","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib43","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00861-2024","article-title":"Integrating hot topics and implementation of treatable traits in asthma","volume":"64","author":"Gibson","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib44","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jaip.2024.01.044","article-title":"Targeting asthma remission as the next therapeutic step toward improving disease control","volume":"12","author":"Busse","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib45","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.chest.2023.04.028","article-title":"Are we ready for asthma remission as a clinical outcome?","volume":"164","author":"Lugogo","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib46","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/S0140-6736(22)02125-0","article-title":"Asthma","volume":"401","author":"Porsbjerg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S2213-2600(23)00415-0","article-title":"Pioneering a paradigm shift in asthma management: remission as a treatment goal","volume":"12","author":"Lommatzsch","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/all.15867","article-title":"Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients","volume":"79","author":"Thomas","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.05.002_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2024.100356","article-title":"Highlights of the Spanish Asthma Guidelines (GEMA), Version 5.4","volume":"6","author":"Plaza","year":"2024","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.jaip.2025.05.002_bib50","series-title":"Practical guidelines for asthma management (PGAM)","author":"Sagara","year":"2023"},{"key":"10.1016\/j.jaip.2025.05.002_bib51","first-page":"461","article-title":"Diagnosis and treatment of asthma: a guideline for respiratory specialists 2023 - published by the German Respiratory Society (DGP) e.V. [in German]","volume":"77","author":"Lommatzsch","year":"2023","journal-title":"Pneumologie"},{"key":"10.1016\/j.jaip.2025.05.002_bib52","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1016\/j.jaip.2023.07.041","article-title":"Severe Asthma Network Italy definition of clinical remission in severe asthma: a Delphi consensus","volume":"11","author":"Canonica","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1150162","article-title":"Remission outcomes in severe eosinophilic asthma with mepolizumab therapy: analysis of the REDES study","volume":"14","author":"Pavord","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib54","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.chest.2023.10.046","article-title":"Clinical response and remission in patients with severe asthma treated with biologic therapies","volume":"165","author":"Hansen","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2213-2600(24)00293-5","article-title":"Clinical remission attainment, definitions, and correlates among patients with severe asthma treated with biologics: a systematic review and meta-analysis","volume":"13","author":"Shackleford","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1343362","article-title":"Features of severe asthma response to anti-IL5\/IL5r therapies: identikit of clinical remission","volume":"15","author":"Carpagnano","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00819-2023","article-title":"Clinical remission in severe asthma with biologic therapy: an analysis from the UK Severe Asthma Registry","volume":"62","author":"McDowell","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib58","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.chest.2024.02.048","article-title":"Azithromycin induced asthma remission in adults with persistent uncontrolled asthma: a secondary analysis of a randomised, double-blind, placebo-controlled trial","volume":"166","author":"Thomas","year":"2024","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib59","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jaip.2025.05.002_bib60","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/ard-2022-223365","article-title":"Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis","volume":"82","author":"Kerschbaumer","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaip.2025.05.002_bib61","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-2600(22)00490-8","article-title":"A2BCD: a concise guide for asthma management","volume":"11","author":"Lommatzsch","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib62","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0140-6736(17)30879-6","article-title":"After asthma: redefining airways diseases","volume":"391","author":"Pavord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib63","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/thorax-2023-221329","article-title":"Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease","volume":"79","author":"Petousi","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.05.002_bib64","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/cea.12881","article-title":"The current and future role of biomarkers in type 2 cytokine-mediated asthma management","volume":"47","author":"Pavord","year":"2017","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.05.002_bib65","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/thoraxjnl-2021-217325","article-title":"Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide","volume":"77","author":"Couillard","year":"2022","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.05.002_bib66","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.chest.2021.10.015","article-title":"Using fractional exhaled nitric oxide measurement in clinical asthma management","volume":"161","author":"Rupani","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib67","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaip.2023.01.008","article-title":"Toward a predict and prevent approach in obstructive airway diseases","volume":"11","author":"Couillard","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib68","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(02)11679-5","article-title":"Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial","volume":"360","author":"Green","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib69","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mai.2003.1382","article-title":"Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics","volume":"111","author":"Menzies-Gow","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib70","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/WOX.0b013e31821188e0","article-title":"Interleukin-13 signaling and its role in asthma","volume":"4","author":"Rael","year":"2011","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2025.05.002_bib71","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jaci.2007.03.048","article-title":"Eosinophil trafficking in allergy and asthma","volume":"119","author":"Rosenberg","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib72","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1440-1843.2006.00784.x","article-title":"Inflammatory subtypes in asthma: assessment and identification using induced sputum","volume":"11","author":"Simpson","year":"2006","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2025.05.002_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1183\/09031936.01.00092101","article-title":"The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics","volume":"18","author":"Soler","year":"2001","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib74","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/cea.14359","article-title":"Effectiveness of FeNO-guided treatment in adult asthma patients: a systematic review and meta-analysis","volume":"53","author":"Korevaar","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.05.002_bib75","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib76","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.chest.2023.04.030","article-title":"Predicting on-biologic remission in asthma: insight from the airways","volume":"163","author":"Couillard","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib77","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/j.jaip.2023.05.047","article-title":"Response to biologics and clinical remission in the adult German Asthma Net Severe Asthma Registry cohort","volume":"11","author":"Milger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib78","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12931-018-0742-y","article-title":"Adverse events profile of oral corticosteroids among asthma patients in the UK: cohort study with a nested case-control analysis","volume":"19","author":"Bloechliger","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2017.04.009","article-title":"Oral corticosteroid exposure and adverse effects in asthmatic patients","volume":"141","author":"Sullivan","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib80","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jaip.2024.10.024","article-title":"Longitudinal assessment of glucocorticoid toxicity reduction in patients with severe asthma treated with biologic therapies","volume":"13","author":"McDowell","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib81","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/thoraxjnl-2015-207326","article-title":"Research in progress: Medical Research Council United Kingdom Refractory Asthma Stratification Programme (RASP-UK)","volume":"71","author":"Heaney","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.05.002_bib82","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.jaip.2022.12.019","article-title":"A randomized trial of a composite T2-biomarker strategy adjusting corticosteroid treatment in severe asthma: a post hoc analysis by sex","volume":"11","author":"Eastwood","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib83","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.jaip.2022.03.020","article-title":"Dupilumab efficacy in steroid-dependent severe asthma by baseline oral corticosteroid dose","volume":"10","author":"Domingo","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib84","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00009-2019","article-title":"Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial","volume":"5","author":"Menzies-Gow","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib85","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jaip.2019.09.036","article-title":"Efficacy of intravenous reslizumab in oral corticosteroid-dependent asthma","volume":"8","author":"Nair","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib86","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1016\/j.jaip.2022.05.042","article-title":"REALITI-A study: real-world oral corticosteroid-sparing effect of mepolizumab in severe asthma","volume":"10","author":"Pilette","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib87","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1016\/j.jaip.2024.08.008","article-title":"Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION","volume":"12","author":"Wechsler","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib88","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s40265-021-01597-9","article-title":"REal worlD effectiveness and safety of mepolizumab in a multicentric Spanish cohort of asthma patients stratified by eosinophils: the REDES study","volume":"81","author":"Domingo Ribas","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jaip.2025.05.002_bib89","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S2213-2600(21)00004-7","article-title":"The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study","volume":"9","author":"McDowell","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib90","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.pulmoe.2023.11.004","article-title":"Are we overlooking the lung function in the definition of severe asthma remission?","volume":"30","author":"Nolasco","year":"2024","journal-title":"Pulmonology"},{"key":"10.1016\/j.jaip.2025.05.002_bib91","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01785-2017","article-title":"Predictors of accelerated decline in lung function in adult-onset asthma","volume":"51","author":"Coumou","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib92","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02536-2017","article-title":"Associations between blood eosinophils and decline in lung function among adults with and without asthma","volume":"51","author":"Hancox","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib93","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00838-2020","article-title":"High eosinophil counts predict decline in FEV1: results from the CanCOLD study","volume":"57","author":"Tan","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib94","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1136\/thorax-2023-220972","article-title":"Type-2 inflammation and lung function decline in chronic airway disease in the general population","volume":"79","author":"Colak","year":"2024","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2025.05.002_bib95","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00204-2019","article-title":"Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma","volume":"6","author":"Castro","year":"2020","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib96","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jaip.2021.09.023","article-title":"Anti-interleukin-5 therapy is associated with attenuated lung function decline in severe eosinophilic asthma patients from the Belgian Severe Asthma Registry","volume":"10","author":"Graff","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib97","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0140-6736(23)02284-5","article-title":"Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study","volume":"403","author":"Jackson","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib98","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-2600(23)00187-X","article-title":"Cough and cough hypersensitivity as treatable traits of asthma","volume":"11","author":"Lai","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib99","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(21)02348-5","article-title":"Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials","volume":"399","author":"McGarvey","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2025.05.002_bib100","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03205-2021","article-title":"An observational study to determine the relationship between cough frequency and markers of inflammation in severe asthma","volume":"60","author":"Holmes","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib101","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00076-2018","article-title":"Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma","volume":"4","author":"Katsaounou","year":"2018","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib102","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2147\/JAA.S296147","article-title":"The patients' experience of severe asthma add-on pharmacotherapies: a qualitative descriptive study","volume":"14","author":"Clark","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.05.002_bib103","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00497-2020","article-title":"What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance","volume":"7","author":"Clark","year":"2021","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib104","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00837-2022","article-title":"Narrative review to capture patients' perceptions and opinions about non-response and response to biological therapy for severe asthma","volume":"61","author":"Coleman","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00240-2020","article-title":"Identification of asthma phenotypes based on extrapulmonary treatable traits","volume":"57","author":"Freitas","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib106","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/17476348.2020.1812388","article-title":"An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma","volume":"14","author":"Castagnoli","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/JAA.S290424","article-title":"Burden of disease in chronic rhinosinusitis with nasal polyps","volume":"14","author":"Bachert","year":"2021","journal-title":"J Asthma Allergy"},{"key":"10.1016\/j.jaip.2025.05.002_bib108","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaip.2020.09.063","article-title":"Chronic rhinosinusitis with nasal polyps and asthma","volume":"9","author":"Laidlaw","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib109","article-title":"Chronic rhinosinusitis with nasal polyps and allergic rhinitis as different multimorbid treatable traits in asthma","volume":"2","author":"Castillo","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"10.1016\/j.jaip.2025.05.002_bib110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jaci.2022.10.026","article-title":"The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis","volume":"151","author":"Rank","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib111","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1378\/chest.08-1702","article-title":"Gastroesophageal reflux disease is associated with poor asthma control, quality of life, and psychological status in Chinese asthma patients","volume":"135","author":"Cheung","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib112","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1164\/rccm.200904-0625OC","article-title":"Effects of asymptomatic proximal and distal gastroesophageal reflux on asthma severity","volume":"180","author":"DiMango","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib113","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1442-2050.2012.01399.x","article-title":"Association of gastroesophageal reflux disease with asthma control","volume":"26","author":"Liang","year":"2013","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaip.2025.05.002_bib114","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/resp.12838","article-title":"Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life","volume":"21","author":"Tay","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/j.jaip.2025.05.002_bib115","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/j.jaip.2021.09.003","article-title":"Asthma and three colinear comorbidities: obesity, OSA, and GERD","volume":"9","author":"Althoff","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib116","doi-asserted-by":"crossref","DOI":"10.1111\/pai.13655","article-title":"Gastroesophageal reflux disease and asthma exacerbation: a systematic review and meta-analysis","volume":"33","author":"Mallah","year":"2022","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.05.002_bib117","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJMcp2114026","article-title":"Gastroesophageal reflux disease","volume":"387","author":"Fass","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib118","doi-asserted-by":"crossref","first-page":"27","DOI":"10.14309\/ajg.0000000000001538","article-title":"ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease","volume":"117","author":"Katz","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaip.2025.05.002_bib119","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cgh.2022.01.025","article-title":"AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review","volume":"20","author":"Yadlapati","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jaip.2025.05.002_bib120","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1016\/j.jaip.2024.01.028","article-title":"Living with asthma and vocal cord dysfunction\/inducible laryngeal obstruction: \"I just can't get air in.\"","volume":"12","author":"Majellano","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib121","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1164\/rccm.201010-1604OC","article-title":"Abnormal vocal cord function in difficult-to-treat asthma","volume":"184","author":"Low","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib122","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaip.2021.10.039","article-title":"A multidisciplinary team clinic for vocal cord dysfunction reduces corticosteroid burst therapy","volume":"10","author":"Fukusho","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib123","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.201606-1249CI","article-title":"Laryngeal dysfunction: assessment and management for the clinician","volume":"194","author":"Hull","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib124","article-title":"Multidisciplinary management of inducible laryngeal obstruction and breathing pattern disorder","volume":"19","author":"Ludlow","year":"2023","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.jaip.2025.05.002_bib125","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jaip.2018.10.046","article-title":"Association between asthma and depression: a national cohort study","volume":"7","author":"Choi","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.rmed.2019.06.025","article-title":"Depression is associated with poor control of symptoms in asthma and rhinitis: a population-based study","volume":"155","author":"Grosso","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib127","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.jaip.2018.01.010","article-title":"A randomized, double-blind, placebo-controlled trial of escitalopram in patients with asthma and major depressive disorder","volume":"6","author":"Brown","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107099","article-title":"Evaluating the effect of antidepressants on the relationship between depression and asthma","volume":"207","author":"Theodoro","year":"2023","journal-title":"Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib129","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaip.2024.01.020","article-title":"Treatable traits in asthma: the importance of extrapulmonary traits-GERD, CRSwNP, atopic dermatitis, and depression\/anxiety","volume":"12","author":"McDonald","year":"2024","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib130","article-title":"Digital interventions to improve adherence to maintenance medication in asthma","volume":"6","author":"Chan","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2025.05.002_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2015.46","article-title":"Towards tailored and targeted adherence assessment to optimise asthma management","volume":"25","author":"van Boven","year":"2015","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaip.2025.05.002_bib132","series-title":"Complex breathlessness","first-page":"186","article-title":"Complex breathlessness: assessment of treatment adherence and treatable traits","author":"McLoughlin","year":"2022"},{"key":"10.1016\/j.jaip.2025.05.002_bib133","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.chest.2016.03.041","article-title":"Systematic review of errors in inhaler use: has patient technique improved over time?","volume":"150","author":"Sanchis","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib134","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12931-017-0710-y","article-title":"Critical inhaler errors in asthma and COPD: a systematic review of impact on health outcomes","volume":"19","author":"Usmani","year":"2018","journal-title":"Respir Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib135","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chest.2021.09.042","article-title":"Prevalence, deaths, and disability-adjusted life-years due to asthma and its attributable risk factors in 204 countries and territories, 1990-2019","volume":"161","author":"Safiri","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2025.05.002_bib136","article-title":"Smoking and lung function among adults with newly onset asthma","volume":"6","author":"Jaakkola","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.jaip.2025.05.002_bib137","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1016\/j.jaip.2018.02.027","article-title":"A systematic review of associations of physical activity and sedentary time with asthma outcomes","volume":"6","author":"Cordova-Rivera","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib138","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaip.2017.09.022","article-title":"Physical activity and exercise capacity in severe asthma: key clinical associations","volume":"6","author":"Cordova-Rivera","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.05.002_bib139","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00546-2022","article-title":"Increasing physical activity in severe asthma: a systematic review and meta-analysis","volume":"60","author":"McLoughlin","year":"2022","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2025.05.002_bib140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.chest.2023.03.001","article-title":"Clinical remission in severe asthma: how to move from theory to practice","volume":"164","author":"Menzies-Gow","year":"2023","journal-title":"Chest"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825004246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219825004246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:42:50Z","timestamp":1755650570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219825004246"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":139,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213219825004246"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.05.002","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatable Traits as a Pathway to Remission in Asthma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2025 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}